Microvast Holdings, Inc.MVSTNASDAQ
Loading

Latest News

Microvast: Growth Story At Risk As Backlog Continues To Shrink
seekingalpha.com

Microvast: Growth Story At Risk As Backlog Continues To Shrink

Microvast Holdings suffered a sharp stock decline after a weak Q4, missing revenue estimates and reporting a significant impairment charge. Despite annual revenue growth of 12.6% and a swing to non-GAAP profitability, MVST's backlog halved, raising concerns about future revenue growth. Management offered minimal guidance for 2026, further unsettling investors amid ongoing backlog declines and uncertainty around new contract wins.

INVESTOR ALERT: Investigation of Microvast Holdings, Inc. (MVST) announced by Holzer & Holzer, LLC
newsfilecorp.com

INVESTOR ALERT: Investigation of Microvast Holdings, Inc. (MVST) announced by Holzer & Holzer, LLC

Atlanta, Georgia--(Newsfile Corp. - March 17, 2026) - Holzer & Holzer, LLC is investigating whether Microvast Holdings, Inc. ("Microvast" or the "Company") (NASDAQ: MVST) complied with federal securities laws. On March 16, 2026, Microvast announced its consolidated financial results for the fourth quarter and full fiscal year ended December 31, 2025, and reported that its gross margin decreased compared to 2024, which the Company said was "primarily attributable to a $32.5 million inventory impairment charge related to specialized ESS components[.

Microvast Stock Slides On Q4 Earnings Miss
benzinga.com

Microvast Stock Slides On Q4 Earnings Miss

Microvast posted an adjusted fourth-quarter loss of 11 cents per share, missing the analyst consensus estimate for earnings of 2 cents. Revenue came in at $96.4 million, also below expectations of $133.8 million and down about 15% from $113.4 million a year earlier.

Microvast: Sell On Dismal Quarter And Poor Near-Term Prospects
seekingalpha.com

Microvast: Sell On Dismal Quarter And Poor Near-Term Prospects

Microvast reported disappointing Q4/2025 results, with sales coming in well below expectations and profitability impacted by sizeable impairment charges. Backlog declined to a new multi-year low. Given this issue, management's stated expectation for continued revenue growth in 2026 appears elusive. With customers delaying or outright canceling new BEV platform launches and disruptions in the Korean market not likely to abate anytime soon, the company's near-term prospects look bleak.

Microvast Schedules Fourth Quarter Earnings Call
globenewswire.com

Microvast Schedules Fourth Quarter Earnings Call

STAFFORD, Texas, March 13, 2026 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a global leader in advanced battery technologies, will issue a press release reporting its consolidated financial results for the full year and fourth quarter of 2025 after market close on Monday, March 16, 2026.

Microvast (NASDAQ:MVST) Director Sells $34,764.96 in Stock
defenseworld.net

Microvast (NASDAQ:MVST) Director Sells $34,764.96 in Stock

Microvast Holdings, Inc. (NASDAQ: MVST - Get Free Report) Director Yixin Pan sold 12,596 shares of the business's stock in a transaction dated Wednesday, December 31st. The shares were sold at an average price of $2.76, for a total value of $34,764.96. Following the completion of the transaction, the director directly owned 130,739 shares of the

Microvast: From 130% Rally To Sharp Pullback, Is The Opportunity Still There?
seekingalpha.com

Microvast: From 130% Rally To Sharp Pullback, Is The Opportunity Still There?

Microvast Holdings remains a buy despite recent volatility, with strong revenue growth and improving operational profitability. MVST delivered record Q3 revenue of $123.3M (+21.6% YoY) and expanded gross margin to 37.6%, but backlog shrinkage raises near-term contract risk. The company's positive cash flow and increased cash position ($142.6M) alleviate prior going concern risks, even as debt remains substantial.

Microvast: Q3 Shows What Happens When Potential Meets Execution
seekingalpha.com

Microvast: Q3 Shows What Happens When Potential Meets Execution

Microvast delivered a solid Q3 with 21.6% YoY revenue growth, improved gross margin, and strong operational execution in a high-potential market. MVST posted positive adjusted EBITDA and higher operating profit, despite a small EPS miss and increased G&A expenses offsetting gross margin gains. Valuation remains attractive, with forward multiples comparing favorably to larger peers, and continued momentum expected as MVST scales and innovates.